| scholarly article | Q13442814 |
| P356 | DOI | 10.1345/APH.1Q383 |
| P698 | PubMed publication ID | 22202494 |
| P2093 | author name string | Heather J Ipema | |
| Maria G Tanzi | |||
| P2860 | cites work | Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery | Q28193941 |
| Hemostatic drugs | Q28277099 | ||
| Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia | Q32084543 | ||
| Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis | Q33413136 | ||
| Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty | Q35355159 | ||
| Absorbable hemostatic agents | Q36514472 | ||
| Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? | Q36634947 | ||
| Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis | Q36709677 | ||
| Pharmacologic methods to reduce perioperative bleeding | Q37095552 | ||
| Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial | Q37253019 | ||
| Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials | Q37325204 | ||
| High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. | Q37649234 | ||
| Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies | Q37684512 | ||
| Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era | Q37794607 | ||
| Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients. | Q37802652 | ||
| Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. | Q37813267 | ||
| Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. | Q37825357 | ||
| 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. | Q37847287 | ||
| A comparison of aprotinin and lysine analogues in high-risk cardiac surgery | Q39102559 | ||
| Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases | Q39432143 | ||
| Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis | Q42420172 | ||
| Effect of topical tranexamic acid in open heart surgery | Q42678877 | ||
| Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. | Q42837549 | ||
| Effect of topical aprotinin on early postoperative bleeding and ICU stay after coronary artery bypass graft surgeries | Q43266537 | ||
| Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. | Q43743645 | ||
| A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema | Q44641943 | ||
| Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid | Q44682665 | ||
| Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study | Q44685522 | ||
| Topical aminocaproic acid in the treatment of traumatic hyphema | Q45106769 | ||
| Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery | Q45264894 | ||
| Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash | Q45270351 | ||
| Primary wound closure in haemophiliacs undergoing dental extractions | Q45883930 | ||
| The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients | Q46237528 | ||
| Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid | Q46772191 | ||
| Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial | Q46803855 | ||
| A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. | Q46988001 | ||
| Tranexamic acid applied topically to achieve haemostasis. | Q51395033 | ||
| Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. | Q51619886 | ||
| Topical aprotinin in cardiac operations. | Q52372487 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tranexamic acid | Q418666 |
| P304 | page(s) | 97-107 | |
| P577 | publication date | 2011-12-27 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures | |
| P478 | volume | 46 |
| Q53652602 | Anti-hemorrhagic agents in oral and dental practice: an update. |
| Q50460458 | Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery. |
| Q28535382 | Efficacy and safety of using antifibrinolytic agents in spine surgery: a meta-analysis |
| Q34523404 | Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial |
| Q38084896 | Enhanced care for primary hip arthroplasty: factors affecting length of hospital stay. |
| Q91236931 | Immunohistochemical Grading of Epidural Fibrosis with CD105 Antibody |
| Q90168870 | Magnetically controlled protein nanocontainers as a drug depot for the hemostatic agent |
| Q38367687 | One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration |
| Q85777100 | Onsets of complications and revisions are not increased after simultaneous bilateral unicompartmental knee arthroplasty in comparison with unilateral procedures |
| Q45968801 | Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid. |
| Q36143953 | Randomized clinical trial of topical tranexamic acid after reduction mammoplasty |
| Q92910023 | Reducing Blood Loss During Abdominal Hysterectomy with Intravenous Versus Topical Tranexamic Acid: A Double-Blind Randomized Controlled Trial |
| Q92151520 | Restrictive allogeneic blood transfusion strategy in patients with extremity bone sarcomas |
| Q34654443 | Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". |
| Q26751278 | Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review |
| Q47917753 | The optimal protocol to reduce blood loss and blood transfusion after unilateral total knee replacement: Low-dose IA-TXA plus 30-min drain clamping versus drainage clamping for the first 3 h without IA-TXA. |
| Q35926609 | Thromboelastography: A Practice Summary for Nurse Practitioners Treating Hemorrhage |
| Q36273712 | Topical versus intravenous tranexamic acid in total knee arthroplasty |
| Q34049595 | Tranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial |
| Q47197183 | Tranexamic acid reduces surgical bleeding: does one size fit all? |
| Q90662028 | Use of Topical Tranexamic Acid to Reduce Blood Loss in Single-Level Transforaminal Lumbar Interbody Fusion |
Search more.